Snf 8815

TargetMol
Product Code: TAR-T26197
Supplier: TargetMol
CodeSizePrice
TAR-T26197-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Snf 8815 is an antagonist of cholecystokinin-B (CCK-B).
CAS:
154336-13-7
Formula:
C56H68N10O13
Molecular Weight:
1089.217
Purity:
0.98
SMILES:
CCCC[C@H](N(C)C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(O)=O)[C@H](C)c1ccccc1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O

References

1. Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH Jr. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology. 1994 Oct;107(4):1135-46. Review. PubMed PMID: 7523219. 2. Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Ann N Y Acad Sci. 1994 Mar 23;713:439-41. PubMed PMID: 8018216. 3. Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 1993 Sep 1;53(17):3925-9. PubMed PMID: 8358719.